Study identifies new way to suppress lung tumors

Study identifies new way to suppress lung tumors
Changes in cell distribution for growth promoting proteins (EGFR;red) when addition of sugar chains is decreased by the inhibitor, NGI-1. Proteins without sites for addition of sugar chains (CRT; green) are unchanged. Credit: Yale University

Lung cancer cell growth depends on certain proteins that require the addition of sugar molecule chains to become active. Scientists have long thought that the addition of these sugar chains is like an on or off switch, and that blocking their addition would be harmful.

Now a Yale-led research team has identified a new blocking mechanism that acts more like a dimmer switch and potently inhibits lung tumor .

Senior author Joseph Contessa and his co-authors screened hundreds of thousands of chemical compounds to uncover a new inhibitor that reduces the addition of without harming non-tumor cells.

Based on this finding, the research team plans to test the compound in preclinical studies as a potential new strategy for treating lung cancer—the leading cause of cancer death nationwide.

Explore further

Inhibiting membrane enzyme may make some cancer cells more vulnerable to chemotherapy

More information: Cecilia Lopez-Sambrooks et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells, Nature Chemical Biology (2016). DOI: 10.1038/nchembio.2194
Journal information: Nature Chemical Biology

Provided by Yale University
Citation: Study identifies new way to suppress lung tumors (2016, October 4) retrieved 20 September 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors